Fabrication of Chrysin-Loaded Hyaluronic Acid Decorated Niosomal Nanoparticles: Potential Anti-inflammatory and Anti-osteoclastic Effects on PBMCs of Rheumatoid Arthritis Patients.

IF 4.1 Q2 PHARMACOLOGY & PHARMACY
Advanced pharmaceutical bulletin Pub Date : 2025-01-05 eCollection Date: 2025-04-01 DOI:10.34172/apb.43185
Sarah Nadhim Sahib, Fadhil Jawad Al-Tu'ma, Atheer Hameed Odda, Maha M Kadhim Al-Tu'ma
{"title":"Fabrication of Chrysin-Loaded Hyaluronic Acid Decorated Niosomal Nanoparticles: Potential Anti-inflammatory and Anti-osteoclastic Effects on PBMCs of Rheumatoid Arthritis Patients.","authors":"Sarah Nadhim Sahib, Fadhil Jawad Al-Tu'ma, Atheer Hameed Odda, Maha M Kadhim Al-Tu'ma","doi":"10.34172/apb.43185","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Rheumatoid arthritis is a persistent autoimmune condition characterized by joint inflammation and degradation, impacting individuals with varying degrees of severity. Chrysin is a natural flavonoid possessing diverse pharmacological properties and antioxidant and anti-inflammation activities. However, chrysin encounters limitations in bioavailability due to its low aqueous solubility and rapid metabolism. Targeted therapy using nanoparticle systems is a novel approach to overcome these difficulties.</p><p><strong>Methods: </strong>The hyaluronic acid-decorated niosomal nanoparticles (NPs) were fabricated using the thin-film hydration method and characterized by various techniques (DLS, AFM, SEM, FT-IR, and drug release pattern analysis). The peripheral blood mononuclear cells (PBMCs) were isolated from blood samples of patients with rheumatoid arthritis, and various factors levels, including nitric oxide, tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-10, total antioxidative capacity (TAC), superoxide dismutase (SOD), glutathione peroxidase (GPx), as well as the expression levels of TIMP1, MMP9, and RANKL genes were evaluated.</p><p><strong>Results: </strong>The fabricated NPs demonstrated spherical morphology with 199±10.7 nm size, 0.653 PDI, and -15.38±2.8 zeta potential. The FT-IR results confirmed the successful incorporation of substances inside niosomal NPs. The treatment with chrysin loaded niosomal NPs successfully decreased the inflammatory agent (nitric oxide), inflammatory cytokines (IL-1β and TNF-α), and osteoclastic related genes (MMP9 and RANKL) expression level. On the other hand, the activity of antioxidant agents (TAC, SOD, and GPx), anti-inflammatory cytokine (IL-10), and anti-osteoclastic related genes (TIMP1) were found to increase.</p><p><strong>Conclusion: </strong>Taken together, the hyaluronic acid-decorated niosomal nano drug delivery system was acceptable in terms of characteristics and was able to direct the chrysin in the vicinity of PBMCs.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"15 1","pages":"95-106"},"PeriodicalIF":4.1000,"publicationDate":"2025-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12235376/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced pharmaceutical bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/apb.43185","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Rheumatoid arthritis is a persistent autoimmune condition characterized by joint inflammation and degradation, impacting individuals with varying degrees of severity. Chrysin is a natural flavonoid possessing diverse pharmacological properties and antioxidant and anti-inflammation activities. However, chrysin encounters limitations in bioavailability due to its low aqueous solubility and rapid metabolism. Targeted therapy using nanoparticle systems is a novel approach to overcome these difficulties.

Methods: The hyaluronic acid-decorated niosomal nanoparticles (NPs) were fabricated using the thin-film hydration method and characterized by various techniques (DLS, AFM, SEM, FT-IR, and drug release pattern analysis). The peripheral blood mononuclear cells (PBMCs) were isolated from blood samples of patients with rheumatoid arthritis, and various factors levels, including nitric oxide, tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-10, total antioxidative capacity (TAC), superoxide dismutase (SOD), glutathione peroxidase (GPx), as well as the expression levels of TIMP1, MMP9, and RANKL genes were evaluated.

Results: The fabricated NPs demonstrated spherical morphology with 199±10.7 nm size, 0.653 PDI, and -15.38±2.8 zeta potential. The FT-IR results confirmed the successful incorporation of substances inside niosomal NPs. The treatment with chrysin loaded niosomal NPs successfully decreased the inflammatory agent (nitric oxide), inflammatory cytokines (IL-1β and TNF-α), and osteoclastic related genes (MMP9 and RANKL) expression level. On the other hand, the activity of antioxidant agents (TAC, SOD, and GPx), anti-inflammatory cytokine (IL-10), and anti-osteoclastic related genes (TIMP1) were found to increase.

Conclusion: Taken together, the hyaluronic acid-decorated niosomal nano drug delivery system was acceptable in terms of characteristics and was able to direct the chrysin in the vicinity of PBMCs.

白玉透明质酸修饰纳米粒子的制备:对类风湿关节炎患者pmcs的潜在抗炎和抗破骨作用。
目的:类风湿关节炎是一种以关节炎症和退化为特征的持续性自身免疫性疾病,影响不同程度严重程度的个体。菊花素是一种天然类黄酮,具有多种药理特性和抗氧化、抗炎活性。然而,由于其低水溶性和快速代谢,菊花素在生物利用度方面受到限制。利用纳米粒子系统进行靶向治疗是克服这些困难的一种新方法。方法:采用薄膜水合法制备透明质酸修饰的纳米粒子,并利用DLS、AFM、SEM、FT-IR和药物释放模式分析等技术对其进行表征。从类风湿性关节炎患者血样中分离外周血单个核细胞(PBMCs),检测一氧化氮、肿瘤坏死因子α (TNF-α)、白细胞介素(IL)-1β、IL-10、总抗氧化能力(TAC)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)等因子水平,以及TIMP1、MMP9、RANKL基因表达水平。结果:制备的纳米粒子呈球形,尺寸为199±10.7 nm, PDI为0.653,zeta电位为-15.38±2.8。FT-IR结果证实了在niosomal NPs内物质的成功结合。白菊花素负载的niosomal NPs成功地降低了炎症因子(一氧化氮)、炎症因子(IL-1β和TNF-α)和破骨细胞相关基因(MMP9和RANKL)的表达水平。另一方面,抗氧化剂(TAC、SOD、GPx)、抗炎细胞因子(IL-10)、抗破骨相关基因(TIMP1)活性升高。结论:综上所述,透明质酸修饰的乳质体纳米给药系统在特性上是可以接受的,并且能够在PBMCs附近引导白杨素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advanced pharmaceutical bulletin
Advanced pharmaceutical bulletin PHARMACOLOGY & PHARMACY-
CiteScore
6.80
自引率
2.80%
发文量
51
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信